학술논문
Hematologic Outcomes and Erythropoiesis-Stimulating Therapy Costs in Epoetin Alfa (EPO)- and Darbepoetin Alfa (DARB)-Treated Cancer Patients: Results of the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (D.O.S.E. Registry).
Document Type
Abstract
Author
Source
In Blood 16 November 2006 108(11):3340-3340
Subject
Language
ISSN
0006-4971